Potential and perspectives of cyclonucleosides

Current Medicinal Chemistry

Volumn 17, Issue 15, 2010, Pages 1527-1549

  Mieczkowski, A ^a,b   Agrofoglio, L A ^a  

^a UNIVERSITÉ D'ORLÉANS   (France)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Antitumoral; Antiviral; Cyclonucleosides; Nucleosides

Indexed keywords

1 (3 AZIDO 2,3 DIDEOXY BETA DEXTRO RIBUFURANOSYL) 5 BROMO 2 (1H)PYRIMIDONE; 1 (3 AZIDO 2,3 DIDEOXY BETA DEXTRO RIBUFURANOSYL) 5 IODO 2 (1H)PYRIMIDONE; 2,3' O CYCLOCYTIDINE; 2,4' O CYCLOCYTIDINE; 2,5' O CYCLOCYTIDINE; 3' O DECANOYL ANTICABINE; 3' O DECANOYL CYTARABINE; 5 (3 BENZYLOXY)BENZYL 2,2' O CYCLOURIDINE; 5 BENZYL 2,2' O CYCLOURIDINE; 5 BROMO 2 PYRIMIDONE BETA DEOXYRIBOSIDE; 5 ETHYNYL 2 PYRIMIDONE BETA DEOXYRIBOSIDE; 5 IODO 2 PYRIMIDONE BETA DEOXYRIBOSIDE; 5 PHENYLETHYNYL 2 PYRIMIDONE BETA DEOXYRIBOSIDE; 5 PROPYNYL 2 PYRIMIDONE BETA DEOXYRIBOSIDE; ACYCLIC NUCLEOSIDE; ANCITABINE; ANTIVIRUS AGENT; CISPLATIN; CYCLONUCLEOSIDE; CYTARABINE; CYTOSINE DERIVATIVE; DAUNORUBICIN; FOSCARNET; GANCICLOVIR; GLYCOSYLTRANSFERASE INHIBITOR; NUCLEOSIDE DERIVATIVE; PURINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; URIDINE DERIVATIVE; VINBLASTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CYTOTOXICITY; DNA DAMAGE; DRUG INHIBITION; DRUG POTENTIATION; DRUG STRUCTURE; ENZYME MECHANISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHATIC LEUKEMIA; NONHUMAN; VIRUS REPLICATION;

ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; CYTARABINE; NUCLEOSIDES; URIDINE;

EID: 77953497423     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710790979962     Document Type: Article

References (269)

1. Clark, V. M.; Todd, A.; Zussman, J. Nucleotides. Part VIII. cycloNucleoside salts. A novel rearrangement of some toluene-psulphonylnucleosides. J. Chem. Soc. 1951, 2952-2958.
2. Ikehara, M. Purine 8-cyclonucleosides. Acc. Chem. Res. 1969, 2, 47-53.
3. Fox, J. J. Pyrimidine nucleoside transformations via anhydronucleoside. Pure Appl. Chem. 1969, 18, 223-255.
4. Sasaki, T.; Minamoto, K.; Itoh, H. Convenient synthesis of some purine 8,5'-imino cyclonucleosides. J. Org. Chem. 1978, 43, 2320-2325.
5. Janeba, Z. Purine 8-Oand 8-S-cyclonucleosides-Synthesis and properties. Chem. Listy 2000, 92, 355-370.
6. Len, C.; Mondon, M.; Lebreton, J. Synthesis of cyclonucleosides having a C-C bridge. Tetrahedron 2008, 64, 7453-7475.
7. 3,5'-Cycloxanthosine, the first natural occurrence of a cyclonucleoside. J. Nat. Prod. 2005, 68, 1689-1691.
8. Hamada, A.; Kawaguchi, T.; Nakano, M. Clinical pharmacokinetics of cytarabine formulations. Clin. Pharmacokinet. 2002, 41, 706-718.
9. Camiener, G. W.; Smith, C. G. Studies of the enzymatic deamination of cytosine arabinoside-I: Enzyme distribution and species specificity. Biochem. Pharmacol. 1965, 14, 1405-1416.
10. Creasey, W. A.; Papac, R. J; Markiw, M. E.; Calabresi, P.; Welch, A. D. Biochemical and pharmacological studies with 1-β-darabinofuranosylcytosine in man Biochem. Pharmacol. 1966, 15, 1417-1428.
11. Hoshi, A.; Kanzawa, F.; Kuretani, K.; Saneyoshi M.; Arai, Y. 2,2'0-Cyclocytidine, an anti-tumor cytidine analog resistant to cytidine deaminase. Gann 1971, 62, 145-146.
12. Walwick, E. R.; Roberts, W.K.; Dekker, C. A. Cyclisation during the phosphorylation of uridine and cytidine by polyphosphoric acid: a new route to the 02,2'-cyclonucleosides. Proc. Chem. Soc. 1959, 84.
13. Ruyle, V. W.; Shen, T. Y. Nucleosides. V. 2-Thiopyrimidine -Darabinofuranosides. J. Med. Chem. 1967, 10, 331-334.
14. Doerr, I. L.; Fox, J. J. Nucleosides. XXXIX. 2'-Deoxy-2'fluorocytidine, 1-.beta.-D-arabinofuranosyl-2-amino-1,4(2H)-4iminopyrimidine, and related derivatives. J. Org. Chem. 1967, 32, 1462-1471.
15. 4-acetylcytidine with partially hydrolyzed phosphorus oxychloride. Chem. Pharm. Bull. 1970, 18, 2569-2571.
16. Kanai, T.; Ichino, M.; Hoshi, A.; Kanzawa, F.; Kuretani, K. Pyrimidine nucleosides. 5. Synthesis of carcinostatic halogenocyclonucleosides. J. Med. Chem. 1972, 15, 1218-1221.
17. Kikugawa, K.; Ichino, M. On the reaction of Vilsmeier-Haack reagent with nucleoside: a convenient synthesis of 2,2-cyclocytidine. Tetrahedron Lett. 1970, 11, 867-870.
18. Kikugawa, K.; Ichino, M. Vilsmeier-Haack reaction. IV. Convenient synthesis of 2,2'-anhydro-1-.beta.-D-arabinofuranosyl cytosine (2,2'-cyclocytidine) and its derivatives. J. Org. Chem. 1972, 37, 284-288.
19. Wechter, W J.; Gish, D. T.; Neil, G. L. Nucleic acids. 12. Synthesis of the L-enantiomer of 1-b-arabinofuranosylcytosine and of O2,O2'-anhydro-1-β-D-arabinofuranosylcytosine. J. Med. Chem. 1971, 14, 882-883.
20. Russell, A. F.; Prystasz, M.; Hamamura, E. K.; Verheyden, J. P. H.; Moffatt, J. G. Reactions of 2-acyloxyisobutyryl halides with nucleosides. V. Reactions with cytidine and its derivatives J. Org. Chem. 1974, 39, 2182-2186.
21. Hamamura, E. K.; Prystasz, M.; Verheyden J. P. H.; Moffatt, J. G.; Yamaguchi, K.; Uchida, N.; Sato; Nomura, A.; Shiratori, O.; Takase, S.; Katagiri, K. Reactions of 2-acyloxyisobutyryl halides with nucleosides. 6. Synthesis and biological evaluation of some 3'-acyl derivatives of 2,2'-anhydro-1-(.beta.-D-arabinofuranosyl)cytosine hydrochloride. J. Med. Chem. 1976, 19, 654-662.
22. Reichman, U.; Chu, C. K.; Hollenberg D. H.; Watanabe K. A. Fox, J. J. Nucleosides XCIX. 2-Acetoxybenzoyl chloride, a reagent for the direct synthesis of 2,2 -anhydro-pyrimidine nucleosides. Synthesis 1976, 533-534.
23. Hamamura, E. K.; Prystasz, M.; Verheyden, J. P.; Moffatt, J. G.; Yamaguchi, K.; Uchida, N.; Sato, K.; Nomura, A.; Shiratori, O. Reactions of 2-acyloxyisobutyryl halides with nucleosides. 7. Synthesis and biological evaluation of some 2,2'-anhydro-1-(3',5'-di-Oacyl--D-arabinofuranosyl)cytosine hydrochlorides. J. Med. Chem. 1976, 19, 663-667.
24. Kondo, K.; Inoue, I. Studies on biologically active nucleosides and nucleotides. 2. A convenient one-step synthesis of 2,2'-anhydro-1- (3',5'-di-O-acyl- -D-arabinofuranosyl)pyrimidines from pyrimidine ribonucleosides. J. Org. Chem. 1977, 42, 2809-2812.
25. Takatsuki, K.-I.; Yamamoto, M.; Ohgushi, S.; Kohmoto, S.; Kishikawa, K.; Yamashita, H. A new protecting group '3,5-O-sulfinyl' for xylo-nucleosides. A simple and efficient synthesis of 3-amino-3 -deoxyadenosine (a puromycin intermediate), 2,2-anhydropyrimidine nucleosides and 2,3-anhydro-adenosine. Tetrahedron Lett. 2004, 45, 137-140.
26. Takatsuki, K.; Ohgushi, S.; Kohmoto, S.; Kishikawa, K.; Yamamoto, M. A simple and efficient synthesis of puromycin, 2,2-anhydro-pyrimidine nucleosides, cytidines and 2,3-anhydroadenosine from 3,5 -O-sulfinyl Xylo-nucleosides. Nucleos. Nucleot. Nucl. 2006, 25, 719-734.
27. Sowa, T.; Tsunoda, K. The Convenient Synthesis of Anhydronucleosides via the 2,3 -O-Sulfinate of Pyrimidine Nucleosides as the Active Intermediates. Bull. Chem. Soc. Jap. 1975, 48, 505-507.
28. Krecmerova, M.; Hrebabecky, H.; Holy, A.Preparation of 5benzyluracil and 5-benzylcytosine nucleosides as potential inhibitors of uridine phosphorylase. Coll. Czech. Chem.Commun. 1996, 61, 627-644.
29. Krecmerova, M.; Hrebabecky, H.; Holy, A. Synthesis of 5phenylcytosine nucleoside derivatives. Coll. Czech. Chem. Commun. 1996, 61, 645-655.
30. Karimian, K. PCT Int. Appl. WO 91/13900, 1991.
31. Nagyvary, J. Arabinonucleotides. II. Synthesis of O2,2'anhydrocytidine 3'-phosphate, a precursor of 1-β-Darabinosylcytosine. J. Am. Chem. Soc. 1969, 91, 5409-5410.
32. Kanai, T.; Ichino, M.; Hoshi, A.; Kuretani, K. Some phosphate esters of cyclocytidine and aracytidine. Tetrahedron Lett. 1971, 12, 1965-1968.
33. Hoshi, A.; Kanzawa, F.; Kuretani, K. Antitumor activity of cyclocytidine in a variety of tumors. Gann 1972, 63, 353-360.
34. Nakahara, W.; Tokuzen, R. Effect of 2,2'-O-cyclocytidine on transplanted lymphocytic sarcoma and reticulum cell sarcoma in mice. Gann 1972, 63, 379-381.
35. Tokuzen, R.; Kuretani, K.; Nakahara, W. Effect of cyclocytidine on spontaneous mammary adenocarcinoma of mice. Gann 1974, 65, 89-91.
36. Hoshi, A.; Kanazawa, F.; Kuretani, K.; Kanai T.; Kikugawa, K. Antitumor activity of cyclocytidine derivatives. Gann 1973, 64, 519-522.
37. Valeriote, F.; Muntz, I. D.; Vietti, T. J. Survival of L1210 leukemia cells and normal hematopoietic stem cells following in vivo administration of cyclocytidine. Invest. New Drugs 1985, 3, 255-261.
38. Hirayama, H.; Sugihara, K.; Wakigawa, K.; Iwamura, M.; Hikita, J.; Ohkuma H. Acute toxicity of cyclocytidine, a new antitumor agent, in mouse and rat. Pharmacometrics 1972, 6, 1255-1258.
39. Hirayama, H.; Sugihara, K.; Wakigawa, K.; Hkita, J.; Sugihara, T.; Kubota, T.; Ohkuma, H.; Oguro, K. General pharmacological properties of cyclocytidine, a new antitnmor agent, in mice and rats. Pharmacometrics 1972, 6, 1259-1266.
40. Hoshi, A.; Kanazawa, F.; Kuretani, K.; Saneyoshi, M.; Arai, Y. 2,2'-O-cyclocytidine, an antitumor cytidine analog resistant to cytidine deaminase. Gann 1971, 62, 145-146.
41. Hoshi, A.; Iigo, M.; Saneyoshi, M.; Kuretani, K. Resistance of cyclocytidine to cytidine deaminase. Chem. Pharm. Bull. 1973, 21, 1535-1538.
42. Hirayama, H.; Sugihara, T.; Sugihara, K.; Wakigawa, K.; Hikita, J.; Ohkuma, H. Carcinogenicity and long-term toxicity study on cyclocytidine, a new antitumor agent. Pharmacometrics 1974, 8, 1693-1712.
43. Hoshi, A.; Kanzawa, F.; Iigo, M.; Kuretani, K. Effect and toxicity of combination treatment including cyclocytidine or cytosine arabinoside in L-1210 and sarcoma-180 systems. Gann 1975, 66, 539-546.
44. Burchenal, J. H.; O'Toole, T.; Kalaher, K.; Chisholm, J. Synergistic effects of the combination of cis-platinum diamminodichloride and 2,2'-anhydro-1--D-arabinofuranosyl-5-fluorocytosine in transplanted mouse leukemias. Cancer Res. 1977, 37, 4098-4100.
45. Hoshi, A.; Yoshida, M.; Kanzawa, F.; Kuretani, K.; Kanai T. Specific inhibition of DNA synthesis by cyclocytidine. Chem. Pharm Bull. 1972, 20, 2286-2287.
46. Hoshi, A.; Yoshida, M.; Kanzawa, F.; Kuretani, K.; Kanai T.; Ichino, M. Inhibition by Cyclocytidine of Nucleic Acid Biosynthesis in Cultured Cells (L5178Y). Chem. Pharm. Bull. 1973, 21, 1446-1450.
47. Kessel, D. On the characteristics of inhibition of deoxyribonucleic acid synthesis by 2,2 -anhydro-1-β-D-arabinofuranosylcytosine. Biochem. Pharmacol. 1974, 23, 2657-2662.
48. Wang, M. C.; Sharma, R. A.; Bloch, A. Studies on the mode of action of 2,2'-anhydro-1-ß-D-arabinofuranosylcytosine. Cancer Res. 1973, 33, 1265-1271.
49. Kirsch, L. E.; Notari, R. E. Aqueous conversion kinetics and mechanisms of ancitabine, a prodrug of the antileukemic agent cytarabine. J. Pharm. Sci. 1984, 73, 896-902.
50. Sato, K.; Nomura, A.; Moffatt, J. G. Antiviral activities of acyl derivatives of 2,2'-anhydro-1-ß-D-arabinofuranosylcytosine and 1ß-D-arabinofuranosylcytosine in cell culture. Antimicrob. Agents Chemother. 1977, 11, 191-197.
51. Nishiyama, S.; Nomura, A.; Yamanaka, T.; Moffatt, J. G. Comparative study of the antiviral activity of acyl derivatives of 2,2'anhydro-1-ß-D-arabinofuranosylcytosine and other nucleosides against encephalitis in mice. Antimicrob. Agents Chemother. 1977, 11, 198-201.
52. Nakamura, K.; Eizuru, Y.; Kumura, K.; Minamishima, Y. Antiviral effect of antileukemic drugs N4-behenoyl-1-beta-Darabinofuranosylcytosine (BH-AC) and 2,2'-anhydro-1--Darabinofuranosylcytosine (cyclo-C) against human cytomegalovirus. J. Med. Virol. 1990, 31, 141-147.
53. Liu, W. G.; Chen, Z. J.; Song, J. Z.; Ma, Z. X. Effects of 2,2'-Ocyclocytidine and acyclovir on latent herpes simplex virus in trigeminal ganglia of mice. Antimicrob. Agents Chemother. 1986, 29, 278-280.
54. Itoh, I. H.; Chu, M. Y.; Chang P. K.; Allaudeen, H. S.; Sartorelli A. C. Evaluation of 2,2 -anhydro-1-(3 -O-acetyl-β-D-arabinofuranosyl)-5-iodocytosine hydrochloride and related compounds as antineoplastic and antiviral agents. Chem.-Biol. Interactions 1981, 33, 215-227.
55. Fox, J. J.; Falco, E. A.; Wempen, I.; Pomeroy, D.; Dowling, M. D.; Burchenal, J. H. Oral and parenteral activity of 2,2'-anhydro-1-ß-Darabinofuranosyl-5-fluorocytosine against both intraperitoneally and intracerebrally inoculated mouse leukemia. Cancer Res. 1972, 32, 2269-2272.
56. Burchenal, J. H.; Currie, V. E.; Dowling, M. D.; Fox J. J.; Krakoff I. H. Experimental and clinical studies on nucleoside analogs as antitulor agents. Ann. N. Y. Acad. Sci. 1975, 255, 202-212.
57. Cook, A. F. Fluorinated pyrimidine nucleosides. 1. Synthesis of a nitrogen analog of the antitumor agent 2,2'-anhydro-1--Darabinofuranosyl-5-fluorocytosine hydrochloride. J. Med. Chem. 1977, 20, 344-348.
58. Chu, C. K.; Reichman, U.; Watanabe K. A.; Fox, J. J. Nucleosides. 107. Synthesis of 5-(-D-arabinofuranosyl)isocytosine and related C-nucleosides. J. Med. Chem. 1978, 21, 96-100.
59. Shealy, Y. F.; O'Dell, C. A. Carbocyclic analog of cytarabine. J. Pharm. Sci. 1979, 68, 668-670.
60. Shealy, Y. F.; O'Dell, C. A. Carbocyclic analogs of cytosine nucleosides J. Heterocyclic Chem. 1980, 17, 353-358.
61. Desai, D. H.; Cheikh A. B.; Zemlicka, J. One-pot synthesis of (±)-1 a-carba-1 a -hydroxycytidine-a new carbocyclic analogue of cytidine. Tetrahedron Lett. 1991, 32, 6281-6284.
62. Perez, N.; Gordillo, B. Rapid synthesis of (±)-r-7benzyloxymethyl-cyclopenta-cis-[4,5][1,3]-oxazolo[3,2a]pyrimidinones versatile carbocyclic nucleoside precursors. Tetrahedron 2003, 59, 671-676.
63. Cook, A. F.; Holman, M. J. Fluorinated pyrimidine nucleosides. 2. Reaction of 2,2'-anhydro-1-.beta.-D-arabinofuranosyl-5-fluorocytosine hydrochloride with nitrogen and sulfur nucleophiles. J. Org. Chem. 1978, 43, 4200-4206.
64. Mizuno, Y.; Sasaki, T. The synthesis of dinucleoside phosphates of natural linkages by the "anhydronucleoside method". Tetrahedron Lett. 1965, 6, 4579-4584.
65. Shuman, D. A.; Robins, M. J.; Robins, R. K. Synthesis of nucleoside sulfamates related to nucleocidin. J. Am. Chem. Soc. 1970, 92, 3434-3440.
66. Ikehara, M.; Uesugi, S. Studies of nucleosides and nucleotides. LV. Reaction of cytidine 5'-monophosphate with p-toluenesulfonyl chloride. Chem. Pharm. Bull. 1973, 21, 264-269.
67. Karimian, K. PCT Int. Appl. WO 91/13901, 1991.
68. Szabo, I. E.; Bruice, T. C. DNG cytidine: synthesis and binding properties of octameric guanidinium-linked deoxycytidine oligomer. Bioorg. Med. Chem. 2004, 12, 4233-4244.
69. Agyei-Aye, K.; Yan, S.; Hebbler, A. K.; Baker D. C. Preparation of 2,3 -anhydropyrimidine nucleosides using N,N-diethylaminosulfur trifluoride (DAST). Nucleos. Nucleot. Nucl. 1989, 8, 327-337.
70. Chen, J.-K.; Schultz, R. G.; Lioyd, D. H.; Gryaznov, S. M. Synthesis of oligodeoxyribonucleotide N3'P5' phosphoramidates. Nucleic Acid Res. 1995, 23, 2661-2668.
71. Seela, F.; Wörner, H.; Rosemeyer, H. 1-(2 -Deoxy--Dxylofuranosyl)cytosine: Base pairing of oligonucleotides with a configurationally altered sugar-phosphate backbone. Helv. Chim. Acta 1994, 77, 883-896.
72. Perbost, M.; Hoshiko, T.; Morvan, F.; Swayze, E.; Griffey, R. H.; Sanghvi, Y. S. Synthesis of 5'-O-amino-2'-deoxypyrimidine and purine nucleosides: building-blocks for antisense oligonucleotides. J. Org. Chem. 1995, 60, 5150-5156.
73. Sabbagh, G.; Fettes, K. J.; Gosain, R.; O'Neil, I. A.; Cosstick, R. Synthesis of phosphorothioamidites derived from 3'-thio-3'deoxythymidine and 3'-thio-2',3'-dideoxycytidine and the automated synthesis of oligodeoxynucleotides containing a 3'-Sphosphorothiolate linkage. Nucleic Acid Res. 2004, 32, 495-501.
74. Gaynor, J. W.; Bentley, J.; Cosstick, R. Synthesis of the 3'-thionucleosides and subsequent automated synthesis of oligodeoxynucleotides containing a 3'-S-phosphorothiolate linkage. Nat. Protoc. 2007, 2, 3122-3135.
75. Meena; Sam, M.; Pierce, K.; Szostak, J. W.; McLaughlin L. W. 2',3'-Dideoxy-3'-thionucleoside triphosphates: Syntheses and polymerase substrate activities. Org. Lett. 2007, 9, 1161-1163.
76. Radatus, B. K.; Karimian, K.; Dajleet, A.; Murthy, K. Pct Int. Appl. WO 95/21183, 1995.
77. Mirzayans, R.; Cubitt, S.; Enns, L.; Karimian, K.; Radatus, B.; Hirani-Hojatti, S.; Murthy, K.; Paterson M. C. Comparative genotoxicity of 2,3'-O-cyclocytidine, ß-xylocytidine and 1-ß-Darabinofuranosylcytosine in human tumor cell lines. Carcinogenesis 1994, 15, 2319-2324.
78. Sasaki, T.; Minamoto, K.; Asano, T.; Miyake, M. Syntheses and properties of some pyrimidine 2,4'-cyclo nucleosides. J. Org. Chem. 1975, 40, 106-111.
79. Andersen, W.; Hayes, D. H.; Michelson, A. M.; Todd, A. Deoxyribonucleosides and related compounds. Part IV. The configuration at the glycosidic centre in deoxyadenosine and deoxycytidine. J. Chem. Soc. 1954, 1882-1887.
80. 2,5-cyclocytidine derivatives with nucleotides. A new approach to the synthesis of the 3 5 internucleotidic bond. Tetrahedron Lett. 1964, 5, 2081-2086.
81. Zemlicka, J. Nucleic acid components and their analogues. XVII. The preparation of 2',3'-O-isopropylidene -O2,5'-cyclocytidine methanesulphonate. Coll. Czech. Chem. Commun. 1967, 32, 1646-1649.
82. Kimura, J.; Yagi, K.; Suzuki, H.; Mitsunobu O. Studies on nucleosides and nucleotides. VIII. Preparation and reactions of triphenylphosphoranediylnucleosides. Bull. Chem. Soc. Jap. 1980, 53, 3670-3677.
83. Pan, G.; Gambhir, S. S.; Toyokuni, T.; Iyer M. R.; Acharya, N.; Phelps, M. E.; Barrio J. R. Rapid synthesis of a 5'-fluorinated oligodeoxy-nucleotide: a model antisense probe for use in imaging with positron emission tomography (PET). Bioorg. Med. Chem. Lett. 1998, 8, 1317-1320.
84. Eisenbarth, J. A. M.; Martin, S. J.; Wagner-Uterman, U.; Eisenhut, M. Pct Int. Appl. WO 03/018599, 2003.
85. Taylor, S. D.; Mirzaei, F.; Bearne, S. L. Bismethylene triphosphate nucleotides of uridine 4-phosphate analogues: a new class of anionic pyrimidine nucleotide analogues. J. Org. Chem. 2008, 73, 1403-1412.
86. Novotn, L.; H ebabeck, H.; Beránek J. Synthesis of the sulfonamido derivatives of arabinonucleosides. Coll. Czech. Chem. Commun. 1985, 50, 383-392.
87. Novotny, L.; Phillips, O.A.; Rauko, P.; Miadokova E. Antileukemic activity of sulfonamide conjugates of arabinosylcytosine. Exp. Oncol. 2006, 28, 293-298.
88. Naito, T.; Hirata, M.; Nakai, Y.; Kobayashi, T.; Kanao, M. The nucleophilic substitution of secondary sulfonyloxy groups of pyrimidine nucleosides. Chem. Pharm. Bull. 1965, 13, 1258-1261.
89. Hampton, A.; Nichol, A. W. Nucleotides. V. Purine ribonucleoside 2',3'-cyclic carbonates. Preparation and use for the synthesis of 5'monosubstituted nucleosides. Biochemistry 1966, 5, 2076-2082.
90. Hirata, M. Studies on Nucleosides and Nucleotides. XI. Nucleophilic substitution of secondary sulfonyloxy groups of pyrimidine nucleosides. IV. Deamination in isocytosine derivatives and dealkoxylation in 2-O-alkyl-pyrimidine nucleosides. Chem. Pharm. Bull. 1968, 16, 437-443.
91. Greenberg, S.; Moffatt, J. G. Reactions of 2-acyloxyisobutyryl halides with nucleosides. I. Reactions of model diols and of uridine. J. Am. Chem. Soc. 1973, 95, 4016-4025.
92. Pankiewicz, K. W.; Watanabe, K. A. Nucleosides. CXLIII. Synthesis of 5'-deoxy-5'-substituted-2,2'-anhydro-1-(beta-D-arabinofuranosyl) uracils. A new 2,5'to 2,2'-anhydro-nucleoside transformation. Studies directed toward the synthesis of 2'-deoxy-2'substituted arabino nucleosides. Chem. Pharm. Bull. 1987, 35, 4494-4497.
93. Michelson, A. M.; Todd, A. R. Deoxyribonucleosides and related compounds. Part V. cycloThymidines and other thymidine derivatives. The configuration at the glycosidic centre in thymidine. J. Chem. Soc. 1955, 816-823.
94. Fox, J. J.; Miller, N. C. Nucleosides. XVI. Further studies of anhydronucleosides. J. Org. Chem. 1963, 28, 936-941.
95. Duschinsky, R.; Eppenberger, U. Nitric acid esters of pyrimidine nucleosides. Tetrahedron Lett. 1967, 8, 5103-5108.
96. Sasaki, T.; Minamoto, K.; Kuroyanagi, S.; Hattori, K. Synthesis of 2,4 -anhydro-1-(5 -deoxy-5 -bromo-2,3 -O-isopropylidene-β-llyxosyl)uracil. Tetrahedron Lett. 1973, 14, 2731-2733.
97. Owen, G. R.; Verheyden, J. P. H.; Moffatt, J. G. 4'-Substituted nucleosides. 3. Synthesis of some 4'-fluorouridine derivatives. J. Org. Chem. 1976, 41, 3010-3017.
98. Kondo, K.; Inoue, I. Studies on biologically active nucleosides and nucleotides. 6. An anodic oxidation of 2',3'-O-isopropylideneuridine-5'-carboxylic acid. J. Org. Chem. 1979, 44, 4713-4716.
99. Cook, S. L.; Secrist, J. A. Nucleoside 4',5'-enol acetates. Synthesis and chemistry of a unique uridine O2,4'-anhydronucleoside. J. Am. Chem. Soc. 1979, 101, 1554-1564.
100. Takasu, H.; Sajiki, H.; Hirota, K. Chemical modification of the sugar moiety of pyrimidine nucleosides via a 4',5'-epoxyuridine intermediate. Heterocycles 2005, 65, 2991-2999.
101. Ueda, T.; Imazawa, M.; Miura, K.; Iwata, R.; Odajima, K. A facile conversion of amino to thiono group in certain nucleobases. Tetrahedron Lett. 1971, 12, 2507-2509.
102. 2,5-cyclodeoxyuridine. Tetrahedron Lett. 1968, 9, 2123-2125.
103. Wada, M.; Mitsunobu, O. Intermolecular dehydration between alcohols and active hydrogen compounds by means of diethyl azodicarboxylate and triphenylphosphine. Tetrahedron Lett. 1972, 13, 1279-1282.
104. Von Schütt, M.; Kowollik, G.; Etzold, G.; Langen, P. Nucleoside von Fluorzuckern. IX. Synthese von Fluorzucker-Nucleosiden aus Uridin und Cytidin. J. Prakt. Chem. 1972, 314, 251-255.
105. Secrist, J. A. A convenient procedure for formation of certain uracil and thymine anhydronucleosides. Carbohyd. Res. 1975, 42, 379-381.
106. 2,5 -cyclouridine. Chem. Lett. 1974, 691-692.
107. Wempen, I.; Fox, J. J. Nucleosides. LV. Synthesis of a sulfurbridged thymine anhydronucleoside and derivatives. J. Org. Chem. 1969, 34, 1020-1025.
108. Ueda, T.; Shibuya, S. Synthesis of Sulfur-Bridged Uracil Anhydronucleosides. Chem. Pharm. Bull. 1970, 18, 1076-1078.
109. Ueda, T.; Shibuya, S. Nucleosides and nucleotides. IX. Synthesis of sulfur-bridged cyclonucleosides: (S)-2, 2'-, 2, 3'-, and 2, 5'cyclo-2-thiouridines. Chem. Pharm. Bull. 1974, 22, 930-937.
110. Shibuya, S.; Kuniaka, A.; Yoshino, H. Direct synthesis of 2, 5'anhydro pyrimidine nucleosides. Chem. Pharm. Bull. 1974, 22, 719-721.
111. Shibuya, S., Ueda, T. Pyrimidine Sand N-cyclonucleosides. Synthesis of 6, 2'(and 5')-Sand N-cyclouridines. Chem. Pharm. Bull. 1980, 28, 939-946.
112. Chen, L. C.; Su, T. L.; Pankiewicz, W. K.; Watanabe, K. A. Nucleosides. 145. Synthesis of 2,5 -anhydro-2-thiouridine and its conversion to 3 -O-acetyl-2,2 -anhydro-5 -chloro-5 -deoxy-2-thiouridine. Studies directed toward the synthesis of 2 -deoxy-2-substituted arabino nucleosides. Nucleos. Nucleot. Nucl.1989, 8, 1179-1188.
113. El Subbagh, H. I.; Ping, L. J.; Abushanab, E. A Stereospecific Synthesis of Pyrimidine -D-2 -Deoxyribonucleosides. Nucleos Nucleot. Nucl. 1992, 11, 603-613.
114. Doerr, I. R.; Cushley, R. J.; Fox, J. J. Nucleosides. L. Synthesis of 2,3'-imino-1-(2-deoxy-.beta.-D-threo-pentofuranosyl)thymine and related derivatives. J. Org. Chem. 1968, 33, 1592-1599.
115. Doerr, I. L.; Fox, J. J. Nucleosides. XL. The introduction of a 2,3'imino bridge into pyrimidine nucleosides. J. Am. Chem. Soc. 1977, 89, 1760-1761.
116. kari, V.; Matuli-Adami, J.; kari, D. Synthesis of 1-(5'deoxy-β-D-erythropent-4'-enofuranosyl)isocytosine and 2-N,5'anhydroisocytidine. Heterocycles 1977, 7, 179-192.
117. Elliott, R. D.; Montgomery, J. A.; Riordan, J. M. A novel two-step conversion of 3',5'-di-O-tosylthymidine to 5'-amino-5'-deoxythymidine analogs with inversion of the 3-hydroxyl group. J. Org. Chem. 1987, 52, 2892-2896.
118. Minamoto, K.; Azuma, K.; Tanaka, T.; Iwasaki, H.; Eguchi, S.; Kadoya, S.; Moroi, M. Syntheses and alkaline hydrolyses of 2,2'iminoand 2,2'-(substituted imino)-1-(2 -deoxy--D-arabinofuranosyl)uracils. J. Chem. Soc. Perkin Trans. I 1988, 2955-2961.
119. Minamoto, K.; Azuma, K.; Fujiwara N.; Eguchi, S.; Hirota, T.; Kadoya, S. Synthesis and alkali-hydrolysis reactions of some 2,3'- (substituted imino)pyrimidine nucleosides lacking a 2'-hydroxyl group. J. Org. Chem. 1989, 54, 4543-4549.
120. Kataleni, D.; kari, V. Azido-(amino-)furanosyl nucleosides and their phosphoramidates. J. Chem. Soc. Perkin Trans. I 1992, 1065-1072.
121. Niedzwicki, J. G.; El Kouni, M. H.; Chu, S. H.; Cha, S. Structureactivity relationship of ligands of the pyrimidine nucleoside phosphorylases. Biochem. Pharmacol. 1983, 32, 399-415.
122. Votruba, I.; Krecmerova, M.; Hrebabecky, H.; Holy, A. Inhibitory Potency of 5-Benzyluracil, 5-Phenylcytosine and 5-Phenylpyrimidin-2-one Nucleosides Against Uridine Phosphorylase from Mouse Leukemic L1210 Cells. Nucleos. Nucleot. Nucl. 1999, 18, 2551-2564.
123. El Kouni, M. H.; Naguib, F. N. M.; Panzica, R. P.; Otter, B. A.; Chu S.-H.; Gosselin, G.; Chu, C. K.; Schinazi, R. F.; Shealy Y. F.; Goudgaon, N.; Ozerou, A. A.; Ueda, T.; Iltzsch, M. H. Effects of modifications in the pentose moiety and conformational changes on the binding of nucleoside ligands to uridine phosphorylase from Toxoplasma gondii. Biochem. Pharmacol. 1996, 51, 1687-1700.
124. Niedzwicki, J. G.; Chu, S. H.; El Kouni, M. H.; Rowe, E. C.; Sungman, C. 5-Benzylacyclouridine and 5-benzyloxybenzylacyclouridine, potent inhibitors of uridine phosphorylase. Biochem. Pharmacol. 1982, 31, 1857-1861.
125. Chu, M.-Y. W.; Naguib, F. N. M.; Iitzsch, M. H.; El Kouli M. H.; Chu, S.-H.; Cha, S.; Calabresi, P. Potentiation of 5-fluoro-2'deoxyuridine antineoplastic activity by the uridine phosphorylase inhibitors benzylacyclouridine and benzyloxybenzylacyclouridine. Cancer Res. 1984, 44, 1852-1856.
126. Veres, Z.; Szabolcs, A.; Szinai, I.; Dénes, G.; Kajtár-Peredy, M.; Ötvös L. 5-Substituted-2,2 -anhydrouridines, potent inhibitors of uridine phosphorylase. Biochem. Pharmacol. 1985, 34, 1737-1740.
127. Drabikowska, A. K.; Lissowska S.; Veres, Z.; Shugar, D. Inhibitor properties of some 5-substituted uracil acyclonucleosides, and 2,2'anhydrouridines versus uridine phosphorylase from E. coli and mammalian sources. Biochem. Pharmacol. 1987, 36, 4125-4128.
128. Veres, Z.; Neszmélyi, A.; Szabolcs, A.; Denes, G.; Kiss, A. I. The effect of the 3 -OH group on the conformation and binding ability of anhydropyrimidine nucleosides to uridine phosphorylase. Arch. Biochem. Biophys. 1991, 286, 1-5.
129. Veres, Z.; Neszmélyi, A.; Szabolcs, A.; Dénes, G. Inhibition of uridine phosphorylase by pyrimidine nucleoside analogs and consideration of substrate binding to the enzyme based on solution conformation as seen by NMR spectroscopy. Eur. J. Biochem. 1988, 178, 173-1816.
130. Chu, S. H.; Weng, Z. Y.; Chen, Z. H.; Rowe, E. C.; Chu, E.; Naguib, F. N. M.; El Kouni, M.; Cha, S.; Chu, M. Y. Synthesis of 5-Benzyl and 5-Benzyloxybenzyl 2,2 -Anhydrouridines and Related Nucleoside Analogs as Inhibitors of Uridine Phosphorylase. Nucleos. Nucleot. Nucl. 1988, 7, 91-102.
131. El Kouni, M. H.; Naguib, F. N. M.; Chu, S. H.; Cha, S.; Ueda, T.; Gosselin, G.; Imbach, J.-L.; Shealy Y. F.; Otter, B. A. Effect of the N-glycosidic bond conformation and modifications in the pentose moiety on the binding of nucleoside ligands to uridine phosphorylase. Mol. Pharmacol. 1988, 34, 104-110.
132. Harnden, M. R. Eur. Pat. Appl. EP 0060099, 1982.
133. Lin, T. S.; Shen, Z.-Y.; August, E. M.; Brankovan, V.; Yang, H.; Ghazzouli, I.; Prusoff, W. H. Synthesis and antiviral activity of several 2,5'-anhydro analogs of 3'-azido-3'-deoxythymidine (AZT), 3'-azido-2',3'-dideoxyuridine (AZU), 3'-azido-2',3'-dideoxy-5halouridines, and 3'-deoxythymidine against human immunodeficiency virus (HIV-1) and Rauscher-Murine leukemia virus (R-MuLV). J. Med. Chem. 1989, 32, 1891-1895.
134. Simpson, M. V.; Chin, C. D.; Keilbaugh, S. E.; Lin, T.-S Prusoff, W. H. Studies on the inhibition of mitochondrial DNA replication by 3 -azido-3 -dhoxythymidine and other dideoxynucleoside analogs which inhibit HIV-1. Biochem. Pharmacol. 1989, 38, 1033-1036.
135. Hobbs, G. A.; Keilbaugh, S. A.; Simpson, M. V. The friend murine erythroleukemia cell, a model system for studying the association between bone marrow toxicity induced by 3'-azido-3'dideoxythymidine and dideoxynucleoside inhibition of mtDNA replication. Biochem. Pharmacol. 1992, 43, 1397-1400.
136. Efange, S. F. N.; Alessi, E. M.; Shih, H. C.; Cheng, Y.-C.; Bardos, T. J. Synthesis and biological activities of 2-pyrimidinone nucleosides. 2. 5-Halo-2-pyrimidinone 2'-deoxyribosides. J. Med. Chem. 1985, 28, 904-910.
137. Efange, S. F. N.; Cheng, Y.-C.; Bardos, T. Synthesis and biological activities of 2-pyrimidinone nucleosides. 5-Alkynyl-2pyrimidinone 2 -deoxyribosides. Nucleos. Nucleot. Nucl. 1985, 4, 545-564.
138. Laland, S. G.; Serck-Hansen, S. Synthesis of pyrimidin-2-one deoxyribosides and their ability to support the growth of the deoxyriboside-requiring organism Lactobacillus acidophilus R 26. Biochem. J. 1964, 90, 76-81.
139. Schroeder, A. C.; Bardos, T. J.; Cheng, Y.-C. Synthesis and antiviral activity of 1-(2-deoxy-.beta.-D-ribofuranosyl)-5-(methylmercapto)-2-pyrimidinone. J. Med. Chem. 1981, 24, 109-112.
140. Efange, S. F. N.; Dutta, A. K. Synthesis and Biological Activity of 5-halo-2-Pyrimidinone 3 -Azido-2,3 -Dideoxyribosides. Nucleos. Nucleot. Nucl. 1991, 10, 1451-1463.
141. Hsu, L.-Y.; Wise, D. S.; Kucera, R. S.; Drach, J. C.; Townsend, L. B. Synthesis of anti-restricted pyrimidine acyclic nucleosides. J. Org. Chem. 1992, 57, 3354-3358.
142. Hsu, L.-Y.; Wise, D. S.; Drach, J. C.; Townsend, L. B. Synthesis of 1-hydroxy-10-methyl-pyrimido [1, 6-C][1, 3]oxazine and the oxazepine derivative, structural mimicry of anti-constrained acyclic thymidine. Nucleos. Nucleot. Nucl. 1996, 15, 1481-1493.
143. Hsu, L.-Y.; Chang, Y.-M.; Lin, C.-H.; Drach, J. C. Synthesis and biological activity of 5-substituted anti-constrained acyclic analogs of cytidine and uridine. Nucleos. Nucleot. Nucl. 1996, 15, 1835-1847.
144. Hsu, L.-Y.; Lin, C.-H. Synthesis and biological evaluation of 3hydroxymethylpyrimido[1,6-c][1,3]oxazine derivatives. Heterocycles 1996, 43, 2687-2699.
145. Hsu, L.-Y.; Kang, Y.-F; Drach, J. C. Synthesis and antiviral evaluation of 3-hydroxymethylpyrimido[1,6-c][1,3]oxazepine derivatives. Heterocycles 1998, 48, 2163-2172.
146. Hsu, L.-Y.; Yang, K.-T. Synthesis and nuclease stability of dinucleotides containing an anticonformationally constrained acyclic thymidine. Nucleos. Nucleot. Nucl. 1999, 18, 2031-2042.
147. Liu, C.-T.; Tu, T.-C.; Hsu, L.-Y. A new synthetic route towards the mono-O-protected anti-conformationally constrained pyrimidine acyclic nucleoside. Chem. Pharm. Bull. 2002, 50, 1028-1030.
148. Sasaki, T.; Minamoto, K.; Kino M.; Mizuno, T. Reactions of the derivatives of 5-bromopyrimidine nucleosides with sodium azide. J. Org. Chem. 1976, 41, 1100-1104.
149. Wang, P.; Stuyver, L.; Watanabe, K. A.; Hassan, A. E. A.; Chun, B.-K.; Hollecker, L.; Pct Int. Appl. WO 2004/013300, 1991.
150. Chun, B.-K.; Wang, P.; Hassan, A.; Du, J.; Tharnish, P. M.; Stuyver, L. J.; Otto, M. J.; Schinazi, R. F., Watanabe, K. A. Synthesis of 5,9-anhydro-3-(-D-ribofuranosyl)xanthine, and 3,5-anhydro-xanthosine as potential anti-hepatitis C virus agents. Tetrahedron Lett. 2005, 46, 2825-2827.
151. Chun, B.-K.; Wang, P.; Hassan, A. E. A.; Du, J.; Tharnish, P.; Murakami, E.; Stuyver, L.; Otto, M. J.; Schinazi, R. F., Watanabe, K. A. Synthesis and biological activity of 5,9-anhydro-3-purineisonucleosides as potential anti-Hepatitis C virus agents. Nucleos Nucleot. Nucl. 2007, 26, 83-97.
152. 3,5'-cyclo-4-(-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one, a novel compound with anti-Hepatitis C Virus activity. J. Med. Chem. 2004, 47, 6100-6103.
153. 3,5-cyclo-4-(-d-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one and its 3 -deoxysugar analogue as potential anti-Hepatitis C Virus agents. Nucleos. Nucleot. Nucl. 2005, 24, 957-960.
154. 3,5'-cyclo-4-(-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one derivatives. J. Med. Chem. 2005, 48, 6454-6460.
155. 3,5-anhydro-4-(-D-ribofuranosyl)-8-azapurin-2-ones. Nucleos. Nucleot. Nucl. 2005, 24, 961-964.
156. 9, 5 -cyclo-3-(-D-ribofuranosyl)-8azapurin-2-one derivatives. Nucleos. Nucleot. Nucl. 2005, 24, 1531-1542.
157. Panczewski, K.; Kahn, N.; Hargrave, P. A. Nucleoside inhibitors of rhodopsin kinase. Biochemistry 1990, 29, 6276-6282.
158. Yoshioka, H.; Yoshioka, H.; Machida, M.; Murakami, K. JP 06-135971 A, 1994.
159. Freist, W.; Wiedner, H.; Cramer F. Chemically modified ATP derivatives for the study of aminoacyl-tRNA synthetases from baker's yeast: ATP analogs with fixed conformations or modified triphosphate chains in the aminoacylation reaction. Bioorg. Chem. 1980, 9, 491-504.
160. Sukuru, S. C. K.; Crepin, T.; Milev, Y.; Marsch L. C.; Hill, J. B.; Anderson, R. J.; Morris, J. C.; Rohatgi, A.; O'Mahony, G.; Grotli, M.; Danel, F.; Page, M. G. P.; Härtlein, M.; Cusack, S.; Kron, M. A., Kuhn, L. A. Discovering new classes of Brugia malayi Asparaginyl-tRNA synthetase inhibitors and relating specificity to conformational change. J. Comput. Aided Mol. Des. 2006, 20, 159-178.
161. 6,2 -cyclonucleosides. Nucleos. Nucleot. Nucl. 1993, 12, 55-71.
162. Motura, M.; Salomon, H.; Moroni, G.; Wainberg, M.; Brinon, M. C. Synthesis, lipophilicity, and anti-HIV activity of a new brominated analog of zidovudine. Nucleos Nucleot. Nucl. 1999, 18, 337-351
163. Ogilvie, K. K.; Slotin, L.; Rheault, P. Novel substrate of adenosine deaminase. Biochem. Biophys. Res. Commun. 1971, 45, 297-300.
164. Ikehara, M.; Fukui, T. Studies of nucleosides and nucleotides. Deamination of adenosine analogs with calf intestine adenosine deaminase. Biochim. Biophys. Acta 1974, 338, 512-519.
165. Hampton, A.; Harper, P. J.; Sasaki, T. Substrate properties of cycloadenosines with adenosine aminohydrolase as evidence for the conformation of enzyme-bound adenosine. Biochemistry 1972, 11, 4736-4739.
166. Matsuda, A.; Fujisawa, Y.; Yamanaka, M.; Tanaka, H.; Ueda, M. T. Synthesis and properties of 2'-deoxy-8,2'-methylenecycloadenosine. Tetrahedron 1985, 41, 6013-6017.
167. Ueda, T. Synthesis and some biological properties of carbonbridged cyclonucleosides and their phosphates. Nucleos. Nucleot. Nucl. 1985, 4, 67-75.
168. Stolarski, R.; Dudycz, L.; Shugar D. NMR Studies on the syn-anti dynamic equilibrium in purine nucleosides and nucleotides. Eur. J. Biochem. 1980, 108, 111-121.
169. Birnbaum, G. I.; Cygler, M.; Dudycz, L.; Stolarski, R.; Shugar, D. Comparison of the solid state and solution conformations of R and S epimers of 8,5'-cycloadenosine and their relevance to some enzymic reactions. Biochemistry 1981, 20, 3294-3301.
170. Dudycz, L.; Shugar, D. Susceptibility to various enzymes of the carbon-bridged (R) and (S) diastereoisomers of 8,5 -cycloadenosine and their 5 -phosphates. FEBS Lett. 1979, 107, 363-365.
171. Jenkins, C. L.; Thiyagarajan, N.; Sweeney, R. Y.; Guy, M. P.; Kelemen, B. R.; Acharya, K. R.; Raines, R. T. Binding of nonnatural 3'-nucleotides to ribonuclease A. FEBS J. 2005, 272, 744-755.
172. Otter, B. A.; Falco, E. A.; Fox, J. J. Nucleosides. 108. Ribo-xylo interconversions of 6,5'-cyclopyrimidine nucleosides via autoxidation and retro-aldol reactions. J. Org. Chem. 1978, 43, 481-486.
173. Ueda, T.; Shuto, S. Synthesis of 6,5'-cyclo-5'-deoxyuridine: A pyrimidine nucleoside fixed in anti conformation. Heterocycles 1982, 17, 95-98.
174. Suzuki, Y.; Matsuda, A.; Ueda, T. Synthesis of 6,5'-cyclo-2',5'dideoxypyrimidine nucleosides (nucleosides and nucleotides. Chem. Pharm. Bull. 1987, 35, 1085-1092.
175. Yoshimura, Y.; Kumamoto, H.; Baba, A.; Takeda, S.; Tanaka, H. Lithiation at the 6-position of uridine with lithium hexamethyldisilazide: crucial role of temporary silylation. Org. Lett. 2004, 6, 1793-1795
176. Ueda, T.; Shuto, S. Synthesis of 6, 5'-cyclo-5'-deoxyuridines by radical cyclization: nucleosides and nucleotides. Chem. Pharm. Bull. 1984, 32, 3410-3416.
177. Matsuda, A.; Ueda, T. Nippon Kagaku Kaishi 1981, 845-850.
178. Hunsucker, S. A.; Mitchell, B. S.; Spychala, J. The 5 -nucleotidases as regulators of nucleotide and drug metabolism. Pharmacol. Ther. 2005, 107, 1-30.
179. Ogilvie, K. K.; Slotin, L. A. Synthesis of nucleotides from 8,2-thioanhydropurine nucleosides. Can. J. Chem. 1973, 51, 2397-2405.
180. Hampton, A.; Harper, P. J.; Sasaki, T. Evidence for the conformation of enzyme-bound adenosine 5'-phosphate. Substrate and inhibitor properties of 8,5'-cycloadenosine 5'-phosphate with adenylate kinase, adenylate aminohydrolase, adenylosuccinate lyase, and 5'-nucleotidase. Biochemistry 1972, 11, 4965-4969.
181. Raleigh, J. A.; Blackburn, B. J. Substrate conformation in 5 -AMPutilizing enzymes: 8,5 -cycloadenosine 5 -monophosphate. Biochem. Biophys. Res. Commun. 1978, 83, 1061-1066.
182. 2,2-cyclouridine. Can. J. Chem. 1974, 52, 1787-1797.
183. Ikehara, M.; Tezuka T. Synthesis of cyclouridine oligonucleotides forming a double stranded complex of left-handedness with cycloadenosine oligonucleotides. J. Am. Chem. Soc. 1973, 95, 4054-4056.
184. Tusa, G.; Reed, J. K. The synthesis of cyclonucleotides with fixed glycosidic bond linkages as putative agonists for P2-purinergic receptors. Nucleos. Nucleot. Nucl. 2000, 19, 805-813.
185. Gupta, M.; Nair, V. Adenosine Deaminase in Nucleoside Synthesis. A Review. Coll. Czech. Chem.Commun. 2006, 71, 769-787.
186. Cadet, J.; Berger, M. Radiation-induced decomposition of the purine bases within DNA and related model compounds. Int. J. Radiat. Biol. 1985, 47, 127-143.
187. Breen, A. P.; Murphy, J. A. Reactions of oxyl radicals with DNA. Free Radic. Biol. Med. 1995, 18, 1033-1077.
188. Dizdaroglu, M.; Jaruga, P.; Birincioglu, M.; Rodriguez, H. Free radical-induced damage to DNA: mechanisms and measurement. Free Radic. Biol. Med. 2002, 32, 1102-1115.
189. Cadet, J.; Douki, T.; Ravanat, J.-T. Oxidatively generated damage to the guanine moiety of DNA: mechanistic aspects and formation in cells. Acc. Chem. Res. 2008, 41, 1075-1083.
190. Wallace, S. S. Biological consequences of free radical-damaged DNA bases. Free Radic. Biol. Med. 2002, 33, 1-14.
191. Cadet, J.; Douki, T.; Gasparutto, D.; Ravanat, J.-L. Oxidative damage to DNA: formation, measurement and biochemical features. Mutat. Res. 2003, 531, 5-23.
192. Cooke, M. S.; Evans, M. D.; Dizdaroglu, M.; Lunec, J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 2003, 17, 1195-1214.
193. Keck, K. Z. Bildung von cyclonucleotiden bei bestrahlung wassriger losungen von purinnucleotiden. Naturforsch. B. 1968, 23, 1034-1043.
194. Mariaggi, N.; Cadet, J.; Teoule, R. Cyclisation radicalaire de la desoxy-2 -adenosine en solution aqueuse, sous l'effet du rayonnement gamma. Tetrahedron 1976, 32, 2385-2387.
195. Raleigh, J. A.; Kremers, W.; Whitehouse, R. Radiation chemistry of nucleotides: 8,5'-cyclonucleotide formation and phosphate release initiated by hydroxyl radical attack on adenosine monophosphates. Radiat. Res. 1976, 65, 414-422.
196. Raleigh, J. A.; Whitehouse, R. Evidence for reductive radiolytic dephosphorylation in the nucleotide analogue 8,5'-cycloadenosine 5 -monophosphate. J. Chem. Soc. Chem. Commun. 1975, 305-306.
197. Haromy, T. P.; Raleigh, J. A.; Sundarlingam, M. Enzyme-bound conformations of nucleotide substrates. X-ray structure and absolute configuration of 8,5'-cycloadenosine monohydrate. Biochemistry 1980, 19, 1718-1722.
198. Fuciarelli, A. F.; Miller, G. G.; Raleigh, J. A. An immunochemical probe for 8,5'-cycloadenosine-5'-monophosphate and its deoxy analog in irradiated nucleic acids. Radiat. Res. 1985, 102, 165-175.
199. Berger, M.; Cadet, J. Radiation chemistry of DNA components. Formation of the 8,5'-cyclo-2',5'-dideoxyguanosine by gamma irradiation of deaerated aqueous solutions of 2'-deoxyguanosine and its 5'-monophosphate ester. Chem. Lett. 1983, 4, 435-438.
200. Matsuda A.; Tezuka, M.; Ueda, T. Photochemical cyclisation of 2',3'-0-isopropylidene-8-phenylthioadenosine to the 8,5'(R)and 8,5'(S)-cycloadenosines (nucleosides and nucleotides). Tetrahedron 1978, 34, 2449-2452.
201. Dizdaroglu, M. Free-radical-induced formation of an 8,5'-cyclo-2'deoxyguanosine moiety in deoxyribonucleic acid. Biochem. J. 1986, 238, 247-254.
202. Dizdaroglu, M.; Dirksen, M.-L.; Jiang, H. X.; Robbins, J. H. Ionizing-radiation-induced damage in the DNA of cultured human cells. Identification of 8,5-cyclo-2-deoxyguanosine. Biochem. J. 1987, 241, 929-932.
203. Flyunt, R.; Bazzanini, R.; Chatgilialoglu, C.; Mulazzani, Q. G. Fate of the 2'-deoxyadenosin-5'-yl radical under anaerobic conditions. J. Am. Chem. Soc. 2000, 122, 4225-4226.
204. Chatgilialoglu, C.; Guerra, M.; Mulazzani, Q. G. Model studies of DNA C5'radicals. Selective generation and reactivity of 2'deoxyadenosin-5'-yl radical. J. Am. Chem. Soc. 2003, 125, 3839-3848.
205. Chatgilialoglu, C.; Duca, M.; Ferreri, C.; Guerra, M.; Ioele, M.; Mulazzani, Q. G.; Strittmatter, H.; Giese, B. Selective generation and reactivity of 5'-adenosinyl and 2'-adenosinyl radicals. Chem. Eur. J. 2004, 10, 1249-1255.
206. Jimenez, L. B.; Encinas, S.; Miranda, M. A.; Navacchia, M. L.; Chatgilialoglu, C. The photochemistry of 8-bromo-2'deoxyadenosine. A direct entry to cyclopurine lesions. Photochem. Photobiol. Sci. 2004, 3, 1042-1046.
207. Navacchia, M. L.; Manetto, A.; Montevecchi, P. C.; Chatgilialoglu, C. Radical cyclization approach to cyclonucleosides. Eur. J. Org. Chem. 2005, 4640-4648.
208. Navacchia, M. L.; Chatgilialoglu, C.; Montevecchi, P. C. C5'-Adenosinyl radical cyclization. A stereochemical investigation. J. Org. Chem. 2006, 71, 4445-4452.
209. Dizdaroglu, M.; Jaruga, P.; Rodriguez, H. Identification and quantification of 8,5 -cyclo-2 -deoxy-adenosine in DNA by liquid chromatography/ mass spectrometry. Free Radic. Biol. Med. 2001, 30, 774-784.
210. Jaruga, P.; Birincioglu, M.; Rodriguez, H.; Dizdaroglu, M. Mass spectrometric assays for the tandem lesion 8,5'-cyclo-2'deoxyguanosine in mammalian DNA. Biochemistry 2002, 41, 3703-3711.
211. Fuciarelli, A. F.; Miller, G. G.; Raleigh, J. A. An immunochemical probe for 8,5'-cycloadenosine-5'-monophosphate and its deoxy analog in irradiated nucleic acids. Radiat. Res. 1985, 104, 272-283.
212. Fuciarelli, A. F.; Mele, F. G.; Raleigh, J. A. Interaction of nitroaromatic radiosensitizers with irradiated polyadenylic acid as measured by an indirect immunochemical assay with specificity for the 8,5'-cycloadenosine moiety. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 1987, 51, 629-639.
213. Fuciarelli, A. F.; Shum, F. Y.; Raleigh, J. A. Intramolecular cyclization in irradiated nucleic acids: correlation between highperformance liquid chromatography and an immunochemical assay for 8,5'-cycloadenosine in irradiated poly(A). Radiat. Res. 1987, 110, 35-44.
214. Birincioglu, M.; Jaruga, P.; Chowdhury, G.; Rodriguez, H.; Dizdaroglu, M.; Gates, K. S. DNA base damage by the antitumor agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (Tirapazamine). J. Am. Chem. Soc. 2003, 125, 11607-11615.
215. Miaskiewicz, K.; Miller, J. H.; Fuciarelli, A. F. Theoretical analysis of DNA intrastrand cross linking by formation of 8,5'cyclodeoxyadenosine. Nucleic Acids Res. 1995, 23, 515-521.
216. Karwowski, B. T; Gaillard, J.; Grand, A.; Cadet, J. Effect of (5 S)-5,8-cyclo-2'-deoxyadenosine on the conformation of di and trinucleotides. A NMR and DFT study. Org. Biomol. Chem. 2008, 6, 3408-3413.
217. Wallace, S. S. Enzymatic processing of radiation-induced free radical damage in DNA. Radiat. Res. 1998, 150, s60-s79.
218. Brooks, P. J.; Wise, D. S.; Berry, D. A.; Komoski, J. V.; Smerdon, M. J.; Somers, R. L.; Mackie, H.; Spoonde, A. Y.; Ackerman, E. J.; Coleman, K.; Tarone, R. E.; Robbins, J. H. The oxidative DNA lesion 8,5'-(S)-cyclo-2'-deoxyadenosine is repaired by the nucleotide excision repair pathway and blocks gene expression in mammalian cells. J. Biol. Chem. 2000, 275, 22355-22362.
219. Kuraoka, I.; Bender, C.; Romieu, A.; Cadet, J.; Wood, R. D.; Lindahl, T. Removal of oxygen free-radical-induced 5,8-purine cyclodeoxynucleosides from DNA by the nucleotide excisionrepair pathway in human cells. Proc. Natl. Acad. Sci. USA 2000, 97, 3832-3837.
220. Brooks, P. J. DNA repair in neural cells: basic science and clinical implications. Mutat. Res. 2002, 509, 93-108.
221. Kuraoka, I.; Robins, P.; Masutani, C.; Hanaoka, F.; Gasparutto, D.; Cadet, J.; Wood, R. D.; Lindahl, T. Oxygen free radical damage to DNA. Translesion synthesis by human DNA polymerase and resistance to exonuclease action at cyclopurine deoxynucleoside residues. J. Biol. Chem. 2001, 276, 49283-49288.
222. Marietta, C.; Gulam, H.; Brooks, P. J. A single 8,5'-cyclo-2'deoxyadenosine lesion in a TATA box prevents binding of the TATA binding protein and strongly reduces transcription in vivo. DNA Repair 2002, 1, 967-975.
223. Jaruga, P.; Theruvathu, J.; Dizdaroglu, M.; Brooks, P. J. Complete release of (5'S)-8,5'-cyclo-2'-deoxyadenosine from dinucleotides, oligodeoxynucleotides and DNA, and direct comparison of its levels in cellular DNA with other oxidatively induced DNA lesions. Nucleic Acids Res. 2004, 32, e87.
224. Romieu, A.; Gasparutto, D.; Molko D.; Cadet, J. Site-Specific Introduction of (5'S)-5',8-Cyclo-2'-deoxyadenosine into Oligodeoxyribonucleotides. J. Org. Chem. 1998, 63, 5245-5249.
225. Romieu, A.; Gasparutto, D.; Molko D.; Cadet, J. Synthesis and Characterization of Oligodeoxynucleotides Containing 5,8-Cyclopurine-2 -Deoxyribonucleosides. Nucleos Nucleot. Nucl. 1999, 18, 1331-1333.
226. Romieu, A.; Gasparutto, D.; Cadet, J. Synthesis and characterization of oligonucleotides containing 5',8-cyclopurine 2'deoxyribonucleosides: (5'R)-5',8-cyclo-2'-deoxyadenosine, (5'S)-5',8-cyclo-2'-deoxyguanosine, and (5'R)-5',8-cyclo-2'-deoxyguanosine. Chem. Res. Toxicol. 1999, 12, 412-421.
227. Dirksen, M. L.; Blakely, W. F.; Holwitt, E. Dizdaroglu, M. Effect of DNA conformation on the hydroxyl radical-induced formation of 8,5'-cyclopurine 2'-deoxyribonucleoside residues in DNA. Int. J. Radiat. Biol. 1988, 54, 195-204.
228. 32P-Postlabeling assay for the oxidative DNA Lesion 8,5'cyclo-2'-deoxyadenosine in mammalian tissues. Evidence that four type II I-compounds are dinucleotides containing the lesion in the 3'-nucleotide. J. Biol. Chem. 2001, 276, 36051-36057.
229. Shaw, A. A.; Cadet, J. Formation of cyclopyrimidines via the direct effects of gamma radiation of pyrimidine nucleosides. Int. J. Radiat. Biol. 1988, 54, 987-997.
230. Wagner, J. R.; Decarroz, C.; Berger, M.; Cadet, J. Hydroxylradical-induced decomposition of 2'-deoxycytidine in aerated aqueous solutions. J. Am. Chem. Soc. 1999, 121, 4101-4110.
231. Romieu, A.; Gasparutto, D.; Cadet, J. Synthesis and characterization of oligodeoxynucleotides containing the two 5R and 5S diastereomers of (5'S,6S)-5,6-cyclo-5,6-dihydrothymidine; radiation-induced tandem lesions of thymidine. J. Chem. Soc. Perkin Trans. I 1999, 1257-1263.
232. Muller, E.; Gasparutto, G.; Jaquinod, M.; Romieu, A.; Cadet, J. Chemical and biochemical properties of oligonucleotides that contain (5 S,6S)-cyclo-5,6-dihydro-2 -deoxyuridine and (5 S,6S)cyclo-5,6-dihydrothymidine, two Main radiation-induced degradation products of pyrimidine 2 -deoxyribonucleosides. Tetrahedron 2000, 56, 8689-8701.
233. Muller, E.; Gasparutto, D.; Cadet, J. Chemical synthesis and biochemical properties of oligonucleotides that contain the (5 S,5S,6S)-5',6-cyclo-5-hydroxy-5,6-dihydro-2 -deoxyuridine DNA lesion. ChemBioChem 2002, 3, 534-542.
234. Uhlmann, E.; Peyman, A. Antisense oligonucleotides: a new therapeutic principle. Chem. Rev. 1990, 90, 543-584.
235. Cook, P. D. Making drugs out of oligonucleotides: a brief review and perspective. Nucleos. Nucleot. Nucl. 1999, 18, 1141-1162.
236. Yadava, P. K. Nucleic acid therapeutics: current targets for antisense oligonucleotides and ribozymes. Mol. Biol. Today 2000, 1, 1-16.
237. Dias, N.; Stein, C. A. Antisense oligonucleotides: basic concepts and mechanisms. Mol. Cancer Ther. 2002, 1, 347-355.
238. Kurreck, J. Antisense technologies. Improvement through novel chemical modifications. Eur. J. Biochem. 2003, 270, 1628-1644.
239. Crooke, S. T. Progress in antisense technology. Annu. Rev. Med. 2004, 55, 61-95.
240. Crooke, S. T. Antisense strategies. Curr. Mol. Med. 2004, 4, 465-487.
241. Rayburn, E.; Wang, W.; Zhang, R.; Wang, H. Antisense approaches in drug discovery and development. Prog. Drug Res. 2005, 65, 229-274.
242. Aboul-Fadl, T. Antisense oligonucleotides: the state of the art. Curr. Med. Chem. 2005, 21, 2193-2214.
243. Chan, J. H. P.; Lim, S.; Wong, W. S. F. Antisense oligonucleotides: from design to therapeutic application. Clin. Exp. Pharmacol. Physiol. 2006, 33, 533-540.
244. Field, A. K. Viral targets for antisense oligonucleotides: a mini review. Antiviral Res. 1998, 37, 67-81.
245. Van Aerschot, A. Oligonucleotides as antivirals: dream or realistic perspective? Antiviral Res. 2006, 71, 307-316.
246. Yuan, J.; Lim, T.; Liu, Z.; Qui, D.; Wong, B.; Luo, H.; Si, X.; McManus, B.; Yang, D. Antisense DNA and RNA: Potential Therapeutics for Viral Infection. Anti-Infect. Agents Med. Chem. 2006, 5, 367-377.
247. Spurgers, K. B.; Sharkley, C. M.; Warfield K. L.; Bavari, S. Oligonucleotide antiviral therapeutics: antisense and RNA interference for highly pathogenic RNA viruses. Antiviral Res. 2008, 78, 26-36.
248. Herdewijn, P. Conformationally restricted carbohydrate-modified nucleic acids and antisense technology. Biochim. Biophys. Acta 1999, 1489, 167-179.
249. Grunweller, A.; Hartmann, R. K. Locked nucleic acid oligonucleotides: the next generation of antisense agents? BioDrugs 2007, 21, 235-243.
250. Ikehara, M.; Uesugi, S.; Yasumoto, M. Highly stacked dinucleoside monophosphate derived from adenine 8-cyclonucleosides. J. Am. Chem. Soc. 1970, 92, 4735-4736.
251. Uesugi, S.; Yasumoto, M.; Ikehara, M.; Fang, K. N.; Ts'o, P. O. P. Synthesis and properties of the dinucleoside monophosphate of adenine 8-thiocyclonucleoside. J. Am. Chem. Soc. 1972, 94, 5480-5486.
252. Ikehara, M.; Uesugi, S.; Yano, Y. Left-handed helical polynucleotides with D-sugar phosphodiester backbones. Nat. New Biol. 1972, 240, 16-17.
253. Ikehara, M.; Uesugi, S. Polynucleotides. XVI. Oligomers of 8,2'anhydro-8-mercapto-9-(-D-arabinofuranosyl)adenine 5'monophosphate. J. Am. Chem. Soc. 1972, 94, 9189-9193.
254. Ikehara, M.; Tezuka, T. Polynucleotides. XXVI. Complex formation of polynucleotides derived from formycin and laurusin with cyclonucleoside oligonucleotides. Nucleic Acid Res. 1974, 1, 907-917.
255. Uesugi, S.; Tezuka, T.; Ikehara, M. Polynucleotides.clouridine phosphate. Hybridization with the oligomer of S-cycloadenosine phosphate to form left-handed helical complexes. J. Am. Chem. Soc. 1976, 98, 969-973.
256. Uesugi, S.; Yano, J.; Yano, E.; Ikehara, M. Polynucleotides. 33. Synthesis and properties of the dinucleoside monophosphates containing adenine S-cyclonucleosides and adenosine. Factors determining the stability and handedness of the stacking conformation in a dinucleoside monophosphate. J. Am. Chem. Soc. 1977, 99, 2313-2323.
257. Ikehara, M.; Uesugi, S.; Shida, T. Polynucleotides. LV. Synthesis and properties of dinucleoside monophosphates derived from adenine 8,2'-Sand uracil 6,2'-O-cyclonucleosides. Further support for the left-handed stacking of oligonucleotides giving high-anti base torsion angles. Chem. Pharm. Bull. 1980, 28, 189-197.
258. Muraoka, M.; Takahashi, S.; Yamaguchi, N.; Oda, Y.; Uesugi, S. Synthesis and properties of dinucleoside monophosphates containing 2-aminoadenine 8,2 -Sand uracil 6,2 -O-cyclonucleosides. Nucleos. Nucleot. Nucl. 1990, 9, 205-221.
259. O duplex with high-anti conformation. Biochem. Biophys. Res. Commun. 1987, 144, 930-935.
260. Kawakami, J.; Uesugi, S.; Ikehara, M.; Itoh, T.; Miura, K.; Ohtsuka, E. Monoclonal antibodies with affinity to selfcomplementary left-handed DNA containing cyclonucleosides with high anti conformation. Nucleos Nucleot. Nucl. 1994, 13, 421-427.
261. Uesugi, S.; Lee, B. L.; Ikehara, M.; Kobayashi, Y.; Kyogoku, Y. Hybrid oligomer of cyclonucleotides and deoxynucleotides. A high anti left-handed double helical DNA structure. J. Biomol. Struct. Dyn. 1985, 3, 339-347.
262. Uesugi, S.; Lee, B. L.; Ikehara, M.; Fujii, S.; Tomita, K. Hybrid hexanucleotide duplex containing cyclonucleotides and deoxynucleotides: the d(TA) segment can adopt a high anti left-handed double-helical structure. Biochemistry 1988, 27, 521-525.
263. Monia, B. P.; Lesnik, E. A.; Gonzalez, C.; Lima, W. F.; McGee, D.; Guinosso, C. J.; Kawaski, A. M.; Cook, P. D.; Freier, S. M. Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem. 1993, 268, 14514-14522.
264. Bevierre, M.-C.; de Mesmaeker, A.; Wolf, R. M.; Freier, S. M. Synthesis of 2 -O-methyl-6,3 -ethanouridine and its introduction into antisense oligonucleotides. Bioorg. Med. Chem. Lett. 1994, 4, 237-240.
265. Urata, H.; Miyagoshi H.; Yumoto, T.; Akagi, M. Racemic synthesis of carbocyclic purine nucleoside analogues with restricted glycosyl conformation. J. Chem. Soc. Perkin. Trans. I 1999, 1833-1838.
266. Urata, H.; Miyagoshi H.; Kakuya, H.; Tokumoto, H.; Kawahata, H.; Otake, T.; Akagi, M. Design and racemic synthesis of conformationally restricted carbocyclic pyrimidine nucleoside analogs based on the structure of the L-nucleoside residue in heterochiral DNA. Chem. Pharm. Bull. 1998, 46, 458-461.
267. Urata, H.; Miyagoshi H.; Kumashiro, T.; Mori, K.; Shoji, K.; Akagi, M. Basis for the right-handed helical sense of doublestranded DNA: Formation of the right-handed helix by Loligonucleotides fixed in low-anti glycosyl conformation. J. Am. Chem. Soc. 2001, 123, 4845-4846.
268. Urata, H.; Miyagoshi H.; Kumashiro, T.; Yumoto, T.; Mori, K.; Shoji, K.; Gohda, K.; Akagi, M. Synthesis and hybridization properties of L-oligodeoxynucleotide analogues fixed in a low anti glycosyl conformation. Org. Biomol. Chem. 2004, 2, 183-189.
269. Kumar, T. S.; Madsen, A. S.; Wengel, J.; Hrdlicka, P. J. Synthesis and hybridization studies of 2'-amino-β-L-LNA and tetracyclic "Locked LNA". J. Org. Chem. 2006, 71, 4188-4201.